title: Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011.
abstract: Community services comprise an important part of a country's HIV response. English language cost and cost-effectiveness studies of HIV community services published between 1986 and 2011 were reviewed but only 74 suitable studies were identified, 66% of which were performed in five countries. Mean study scores by continent varied from 42 to 69% of the maximum score, reflecting variation in topics covered and the quality of coverage: 38% of studies covered key and 11% other vulnerable populations - a country's response is most effective and efficient if these populations are identified given they are key to a successful response. Unit costs were estimated using different costing methods and outcomes. Community services will need to routinely collect and analyze information on their use, cost, outcome and impact using standardized costing methods and outcomes. Cost estimates need to be disaggregated into relevant cost items and stratified by severity and existing comorbidities. Expenditure tracking and costing of services are complementary aspects of the health sector 'resource cycle' that feed into a country's investment framework and the development and implementation of national strategic plans.
authors.affiliation: Office of the Deputy Executive Director, Programme Branch, UNAIDS Secretariat, 20 Avenue Appia, Geneva, Switzerland. becke@unaids.org
authors.forename: Eduard J
authors.initials: EJ
authors.lastname: Beck
authors.forename: Olufunke
authors.initials: O
authors.lastname: Fasawe
authors.forename: Patricia
authors.initials: P
authors.lastname: Ongpin
authors.forename: Peter
authors.initials: P
authors.lastname: Ghys
authors.forename: Carlos
authors.initials: C
authors.lastname: Avilla
authors.forename: Paul
authors.initials: P
authors.lastname: De Lay
mesh_terms: D003153:Community Health Services / Q000191:economics / Q000458:organization & administration*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D015658:HIV Infections / Q000191:economics / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000379:methods*; D012720:Severity of Illness Index